+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

EPCLUSA Drug Profile, 2019

  • ID: 4726969
  • Report
  • 78 pages
  • thinkBiotech LLC
1 of 5

FEATURED COMPANIES

  • Asegua Therapeutics Llc
  • Gilead Sciences Inc.
  • MORE
EPCLUSA Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs.

The report focuses on EPCLUSA and covers the following critical aspects of this drug:
  • United States patents
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementatry protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
About the Researcher

The researcher is a provider of global business intelligence on biologic and small-molecule drugs, dedicated to helping clients make better decisions. Critical information on global drug patents is incorporated with litigation intelligence, drug prices, and historic sales figures to help users discover commercial opportunities and forecast future revenue events. Since 2005 the researcher has served hundreds of large and small companies in more than 65 countries.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Asegua Therapeutics Llc
  • Gilead Sciences Inc.
  • MORE
  • Profile for EPCLUSA
  • US Patents
  • US Regulatory Exclusivity
  • US District Court Litigation
  • US Patent Trial and Appeal Board Cases
  • International (ex US) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Drug Prices - Average Pharmacy Cost
  • Drug Prices - Best Wholesale Price
  • Finished Product Suppliers
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Gilead Sciences Inc.
  • Asegua Therapeutics Llc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4726969
Adroll
adroll